Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae

Journal of Infectious Diseases

Volumn 180, Issue 1, 1999, Pages 133-140

  Johnson, Scott E ^a,c   Rubin, Lorry ^b   Romero Steiner, Sandra ^a   Dykes, Janet K ^a   Pais, Lorna B ^a   Rizvi, Atquia ^b   Ades, Edwin ^a   Carlone, George M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTEREMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BACTEREMIA; BACTERIAL CAPSULES; BIOLOGICAL ASSAY; HUMANS; IMMUNIZATION, PASSIVE; MICE; OPSONIN PROTEINS; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033016586     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314845     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
2. Centers for Disease Control and Prevention. Defining the public health impact of drug resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep 1996;45(RR-1):1-20.
3. Centers for Disease Control and Prevention. Pneumococcal polysaccharide vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1989;38:64-8, 73-6.
4. Lee CJ. Bacterial capsular polysaccharides - biochemistry, immunity and vaccine. Mol Immunol 1987;24:1005-19.
5. Oguri T. Clinical and bacteriological studies of Streptococcus pneumoniae.: yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of β-lactam resistant strains. Jpn J Antibiot 1986;39:783-806.
6. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997;24:356-62.
7. Quataert SA, Kirch CS, Quackenbush Wiedl LJ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-SF. Clin Diagn Lab Immunol 1995;2:590-7.
8. Romero-Steiner S, LiButti D, Pais LB, et al. Standardization of an opsonophagocytic assay for the measurement of the functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997;4:415-22.
9. Wenger JD, Steiner SR, Pais L, et al. Laboratory correlates for protective efficacy of pneumococcal vaccines: how can they be identified and validated [abstract G-37]. In: Programs and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996;150.
10. Bowers EF, Jefferies LR. Optochin in the identification of Streptococcus pneumoniae. J Clin Pathol 1955;8:58-60.
11. Bower MK, Thisle LC, Stearman BD, Schaub IG. The optochin sensitivity test: a reliable method for identification of pneumococci. J Lab Clin Med 1957;49:641-2.
12. Plikaytis BD, Holder PF, Pais LB, Maslanka SE, Gheesling LL, Carlone GM. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 1994;32:2441-7.
13. Finney DJ. Statistical method in biological assays. London, UK: Griffin & Co. 1978.
14. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. Phase variation in pneumococcal opacity: relationship between colony morphology and nasopharyngeal colonization. Infect Immun 1994;62:2582-9.
15. Romero-Steiner S, Pais LB, Groover L, et al. Evaluation of functional antibody responses in elderly and middle aged vaccinees to the 23-valent pneumococcal polysaccharide vaccine [abstract E-64]. In: Programs and abstracts of the 97th general meeting of the American Society for Microbiology (Miami). Washington. DC: ASM, 1997:251.
16. Schiffman G, Douglas RM, Bonner MJ, Robbins M, Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anti-capsular antibodies and comparison with other techniques. J Immunol Methods 1980;33:133-44.
17. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk population. Rev Infect Dis 1981;3:S184-96.
18. Musher DM, Groover JE, Rowland JM, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis 1993;17:66-73.
19. Saladino RA, Stack AM, Fleisher GR, et al. Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats. Infect Immun 1997;65:4701-4.
20. Musher DM, Johnson B Jr, Watson DA. Quantitative relationship between anti-capsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun 1990;58:3871-6.
21. Yother JC, Forman C, Gray BM, Briles DE. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun 1982;36:184-8.
22. White B. Pathogenicity of pneumococcus: experimental animals. In: Brattleboro VT, ed. The biology of pneumococcus - the bacteriological, biochemical, and immunological characters and activities of Diplococcus pneumoniae. Brattleboro, VT: EL Hildreth & Co, 1938:179-213.
23. Briles DE, Crain M, Gray BM. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992;60:111-6.
24. Briles DE, Horowitz J, McDaniel LS, et al. Genetic control of the susceptibility to pneumococcal infection. Curr Top Microbiol Immunol 1986;124:103-20.
25. Converse GM III, Dillon HC Jr. Epidemiological studies of Streptococcus pneumoniae in infants: methods of isolating pneumococci. J Clin Microbiol 1977;5:293-6.
26. Stack AM, Malley R, Thompson CM, Kobzik L, Siber GR, Saladino RA. Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats. J Infect Dis 1998;177:986-90.
27. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
28. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
29. Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK. Quantitative measurements of "natural" and immunization-induced Haemaphilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
30. Nahm MH, Olander JV, Magyarlaki M. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J Infect Dis 1997;176:698-703.